Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pilot Study of the Effect of GM-CSF on Macrophages in Incompletely Resected or Recurrent Ependymoma

NCT04408092 is registered in ClinicalTrials.gov with University of Colorado, Denver as lead sponsor.

NCT NCT04408092
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04408092 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pilot Study of the Effect of GM-CSF on Macrophages in Incompletely Resected or Recurrent Ependymoma
Lead sponsor
University of Colorado, Denver
Phase
Phase 1
Overall status
Completed
Start date
June 25, 2013
Completion date
July 21, 2023
Enrollment
6 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

ependymoma, ependymoma, recurrent childhood